Condition: Vaginal Dysbiosis · Sponsor: Procare Health Iberia S.L.
The hypothesis is raised of improving the status of vagnal microbiota with a non-hormonal topical product in early situations of dysbiosis in which the vaginal pH is elevated and the patient may or may not be symptomatic, in order to try to prevent the appearance of future established vaginal infections.
This description comes directly from the study's public registry record.
Josep Combalia, MD · +34 93 645 54 41 · combalia.j@procarehealth.com
Always discuss trial participation with your own doctor first.
| Clínica Sagrada Familia | Barcelona, Spain | Recruiting |
| Instituto Palacios de Salud y Medicina de la Mujer | Madrid, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06668012